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Innate immune responses to pathogens such as bacteria and viruses are triggered by recognition of specific structures of invading pathogens
called pathogen-associated molecular patterns (PAMPs) by cellular pattern recognition receptors (PRRs) that are located at plasma membrane or
inside cells. Stimulation of different PAMPs activates Toll-like receptor (TLR)-dependent and -independent signaling pathways that lead to
activation of transcription factors nuclear factor-κB (NF-κB), interferon regulatory factor 3/7 (IRF3/7) and/or activator protein-1 (AP-1), which
collaborate to induce transcription of a large number of downstream genes. This review focuses on the rapid progress that has recently improved
our understanding of the crosstalk among the pathways and the precise regulation of transcription of the downstream genes.
© 2006 Elsevier Inc. All rights reserved.Keywords: Innate immunity; Signaling pathway; Crosstalk; Regulation of gene transcriptionIntroduction
Recognition of pathogen-associated molecular patterns
(PAMPs) by host pattern recognition receptors (PRRs)
represents a critical step in innate immune responses. In
mammals, recognition of PAMPs by Toll-like receptors (TLRs)
is now well established. Stimulation of TLRs by PAMPs
induces activation and translocation to nucleus of nuclear
factor-κB (NF-κB), interferon regulatory factor 3/7 (IRF3/7)
and/or activator protein-1 (AP-1), which collaborate to induce
transcription of various cytokines such as alpha/beta interferon
(IFN-α/β), leading to clearance of the infectious pathogens.
Among the characterized TLRs, TLR1, 2, 4, 5 and 6 are
represented on the cell surface and seem to specifically
recognize bacterial and fungal products that are not made by
the host, whereas TLR3, 7, 8 and 9 reside in intracellular
endosomes and specialize in the detection of nucleic acids of
pathogens (Akira et al., 2006). For example, lipopolysaccharide
(LPS), a common structure of the cell wall of Gram-negative
bacteria, is recognized by TLR4 (Poltorak et al., 1998); double-⁎ Corresponding author. Fax: +86 27 68753780.
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doi:10.1016/j.virol.2006.04.029stranded RNA (dsRNA), which has long been considered a viral
PAMP, triggers TLR3 signaling (Alexopoulou et al., 2001).
Considering that host nucleic acids are not accessible to the
intracellular endosomes under normal conditions and are always
modified (CpG methylation, for example), host nucleic acids
normally do not elicit TLR signaling (Iwasaki and Medzhitov,
2004).
The idea that TLRs serve as viral sensors has been
challenged by several obstacles such as the contradiction that
distribution of some TLRs is tissue specific but nearly all
nucleated cells respond to viral infection or dsRNA to produce
IFN-α/β (Levy and Marie, 2004). As a result, recognition of
certain PAMPs should involve a TLR-independent system. Of
the best-characterized intracellular PRRs are the nucleotide
binding domain (NOD) proteins NOD1 and NOD2 that
recognize the core structures of bacterial peptidoglycan
(Inohara and Nunez, 2003). Furthermore, IFN-inducible
dsRNA-dependent protein kinase (PKR) was reported to
mediate the intracellular recognition of dsRNA (Hovanessian,
1989; Zheng and Bevilacqua, 2004), although gene-targeting
studies have shown that it is superfluous for IFN-α/β
production in response to viral infection (Yang et al., 1995).
Recently, an RNA helicase, retinoic-acid-inducible gene I (RIG-
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and proved to play an essential role in dsRNA-induced innate
antiviral responses (Yoneyama et al., 2004). A RIG-I-like
protein, melanoma differentiation-associated gene 5 product
(Mda-5, also known as HELICARD), was also shown to be
involved in dsRNA-triggered signaling leading to induction of
type I IFNs (Andrejeva et al., 2004). The signaling pathways
triggered by TLR-dependent and -independent recognition of
PAMPs converge at the activation of NF-κB, IRF3/7 and/or AP-
1, which independently or collaboratively mediate production
of a variety of cytokines such as IFN-α/β.
In this review, we summarize events of TLR-dependent and
-independent signaling cascades triggered by PAMPs. We will
highlight the crosstalk among signaling pathways and signal-,
promoter-, cell-specific as well as systemic controls for precise
regulation of transcription of downstream genes.
TLR signaling cascades
Considerable progress over the past few years has been made
to characterize the mammalian TLRs, each specific for a distinct
ligand set, and the TLR signaling pathways have been
extensively reviewed in several previous publications (Akira,
2003; Vogel et al., 2003; Akira and Takeda, 2004; Akira et al.,
2006). Here, we choose TLR3, TLR4 and TLR9 signaling for
discussion because they signal through three different repre-
sentative adaptor usage and signaling cascades (Vogel et al.,
2003; Akira and Takeda, 2004; Wagner, 2004; Dunne and
O'Neill, 2005; Sen and Sarkar, 2005) (Fig. 1).Fig. 1. Network of TLR3, 4, 9 and VISA-mediated signaling. Stimulated by dsRNA
activate IRF3/7 and NF-κB. TLR9 recognizes CpG DNA and exclusively uses MyD
adaptors to activate IRF3/7, NF-κB and AP-1 upon the stimulation of LPS. RIG-I and
Unknown sensor(s) recognizes B-DNA to induce expression of IFN-β via the adaptTLR3, 4 and 9 signaling
TLR3 signaling has been extensively studied because the
first characterization of TLR3 (Alexopoulou et al., 2001).
Stimulated by viral dsRNA or synthetic poly(I:C), TLR3 signals
through myeloid differentiation primary response protein-88
(MyD88)-independent and Toll/interleukin receptor (TIR)
domain-containing adaptor-inducing IFN-β (TRIF, also
known as TICAM-1)-dependent pathways (Akira and Takeda,
2004; Sen and Sarkar, 2005). Natural or synthetic oligodeox-
ynucleotides (OND) containing an unmethylated CpG motif
(CpG) can activate TLR9, which exclusively couples to the
MyD88-dependent pathway (Akira and Takeda, 2004; Wagner,
2004). LPS has long been identified as ligand for TLR4 via
analysis of mice with a point mutation in the gene encoding
TLR4 (Poltorak et al., 1998). It is compelling that TLR4
functions through both MyD88- and TRIF-dependent path-
ways. In addition, two other adaptors, TIR-containing adaptor
protein (TIRAP, also known as Mal) and TIR-containing protein
(TIRP, also known as TRAM and TICAM-2), participate in
those two pathways, respectively (Bin et al., 2003; Oshiumi et
al., 2003; Vogel et al., 2003; Akira and Takeda, 2004) (Fig. 1).
MyD88-dependent pathway
The MyD88-dependent pathway includes a number of
signaling molecules: the adaptor protein MyD88, IL-1R-
associated kinases (IRAKs), transforming growth factor-β-
activated kinase (TAK1), TAK1 binding protein-1 (TAB1),, TLR3 utilizes TRIF as an adaptor and signals in TRIF-dependent pathways to
88 as an adaptor to activate IRF7. TLR4 makes use of both TRIF and MyD88
Mda-5 are dsRNA sensors and signal via VISA to activate IRF3/7 and NF-κB.
or VISA.
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factor 6 (TRAF6). Upon stimulation of TLRs, MyD88 is
recruited to the TIR domain of TLRs. MyD88 further recruits
IRAK4 to form TLR–MyD88–IRAK4 signal complex. Then
the signal complex (TLR–MyD88–IRAK4) recruits IRAK1
and thereby phosphorylates and activates it. The activated
IRAK1 autophosphorylates residues in its N-terminus, which
leads to recruitment and binding of TRAF6 to the receptor
signaling complex. The IRAK1–TRAF6 complex then disas-
sociates from the receptor and interacts with another complex
consisting of TAK1, TAB1 and TAB2, followed by the
phosphorylation and activation of TAK1 (Akira and Takeda,
2004). The activated TAK1 subsequently activates the IκB
kinases (IKKs), which phosphorylates IκB and leads to
activation of NF-κB. Activation of TAK1 also results in the
activation of MAPKs, including c-Jun N-terminal kinase (JNK),
leading to activation of AP-1 (Ninomiya-Tsuji et al., 1999;
Akira and Takeda, 2004; Sato et al., 2005).
TRIF-dependent pathway
The adaptor protein TRIF has been demonstrated to
interact with the TRAF family-member-associated NF-κB
activator (TANK) binding kinase 1 (TBK1) and IKKε (also
known as IKKi) as well as IRF3/7 and thereby to facilitate
TBK1 and IKKε to phosphorylate and activate IRF3/7.
Besides IKKε and TBK1, TRAF6, IKKβ and receptor–
interactor protein-1 (RIP1) also interact with TRIF (Han et
al., 2004; Xu et al., 2005). The binding of TRAF6 to TRIF
was previously supposed to activate NF-κB (Sato et al.,
2003; Han et al., 2004; Jiang et al., 2004); however, TLR3
signaling (dependent on TRIF) in TRAF6-deficient micro-
phages is not affected (Gohda et al., 2004). Recently, a
study on mouse embryonic fibroblasts (MEFs) derived from
RIP1-deficient mice indicates that RIP1 binding to the C-
terminus of TRIF should be responsible for TRIF-mediated
NF-κB activation (Balachandran et al., 2004; Meylan et al.,
2004). In addition, overexpression of TRIF induces
apoptosis by interaction with RIP1 through a RIP1/Fas-
associated death domain (FADD)/caspase8-dependent and
mitochondria-independent apoptotic pathway (Han et al.,
2004). Collectively, the TRIF-dependent pathways activate
IRF3/7 and NF-κB and induce apoptosis via TBK1/IKKε,
RIP1 and RIP1/FADD/caspase8, respectively.
Signaling triggered by TLR-independent recognition
of PAMPS
There is evidence that NOD1 and NOD2 can recognize
the core structures of bacterial peptidoglycan in the
cytoplasm to activate NF-κB, which is TLR independent
(Inohara et al., 2001; Ogura et al., 2001; Girardin et al.,
2003; Inohara and Nunez, 2003; Inohara et al., 2003).
Although TLR3 and TLR9 function as signaling receptors
for dsRNA and CpG DNA, respectively, to induce
proinflammatory cytokines, several difficulties challenge the
idea that TLRs serve as viral sensors (Levy and Marie,2004). It has been proposed that TLR3 is important for
systemic responses to viral infection but is not required for
the initial, cell-autonomous recognition of viral infection that
induces the first wave of type I IFN production (Honda et
al., 2003; Yoneyama et al., 2004). Recently, it has been
shown that two cytoplasmic RNA helicase proteins, Mda-5
and RIG-I, are sensors of viral dsRNA, which initiate
antiviral responses via the adaptor protein VISA/IPS-1/
MAVS/Cardif (Fig. 1).
Mda-5 and RIG-I
Mda-5 is an IFN-inducible host cell DExD/H box
helicase with two caspase recruitment domains (CARDs) at
its N-terminus. Overexpression of Mda-5 strongly activates
the promoter of IFN-β in reporter gene assays (Andrejeva et
al., 2004), and siRNA-mediated knockdown of Mda-5
expression caused a suppressive effect on Sendai virus
(SenV) induction of IFN-β promoter, indicating that Mda-5
contributes to antiviral responses (Li et al., 2005a). RIG-I,
also an RNA helicase with two CARD domains at its N-
terminus, plays an important role in activation of NF-κB
and IRF3/7 and is essential for antiviral responses in vitro
(Yoneyama et al., 2004). Recently, work by Kato et al.
(2005) showed that the induction of type I IFNs is severely
impaired in RIG-I-deficient MEFs and conventional dendritic
cells (cDCs) after viral infection, revealing an essential role
of RIG-I in viral recognition in vivo. Collectively, these
proteins serve as intracellular viral sensors and trigger
downstream signaling that leads to clearance of infectious
viruses.
VISA/IPS-1/MAVS/Cardif
Recently, we identified and characterized a novel CARD-
containing adaptor protein, virus-induced signaling adaptor
(VISA) (Xu et al., 2005), which was also identified by three
other independent groups via distinct approaches and was
named as interferon-β promoter stimulator 1 (IPS-1) (Kawai
et al., 2005), mitochondrial antiviral signaling (MAVS) (Seth
et al., 2005) and Cardif (Meylan et al., 2005), respectively.
These studies suggest that VISA is an adaptor downstream
of RIG-I and Mda-5 to activate NF-κB and IRF3/7 and is
critical for cellular antiviral responses. In addition, one study
also indicated that VISA is located in the outer mitochon-
drial membrane via its C-terminal transmembrane domain
and mislocalization of VISA impairs its function, connecting
the antiviral responses to mitochondria (Seth et al., 2005).
VISA is also a target of hepatitis C virus (HCV) NS3/4A
protease and the cleavage of VISA by NS3/4A may result in
disruption of innate immune responses and HCV persistence
(Meylan et al., 2005). However, many interesting questions
of this pathway remain to be answered. For instance, VISA
forms a complex with FADD and RIP1 (Kawai et al., 2005),
and it also interacts with TRAF6 in our study (Xu et al.,
2005). Both the RIP1/FADD and the TRAF6/TAK1 path-
ways are sufficient to activate NF-κB. It is worthy of
Fig. 2. Crosstalk of NF-κB and IRF3/7 activation pathways. (A) Crosstalk
between signaling pathways that activate NF-κB. Despite its interaction with
both MyD88 and TRIF in vivo, TRAF6 is required for TLR4-mediated MyD88-
dependent pathway but not TRIF-dependent pathway for activation of NF-κB.
The TRIF-dependent pathway first stimulates activation of IRF3 leading to
production of TNFα, which in turn triggers TNFR signaling to activate NF-κB.
Or alternatively, TRIF interacts with RIP1 to induce NF-κB activation. (B)
Crosstalk between signaling pathways that activate IRF3/7. The TLR3 and
TLR4 initiated signaling pathways converge at TRIF, which signals through
IKKβ, IKKε and/or TBK1 for activation of IRF3/7.
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the pathways in a cell-type-specific manner or whether they
function redundantly to each other.
Crosstalk of signaling
TLR-dependent and -independent signaling pathways trig-
gered by PAMPs share a number of signaling molecules and
cross at molecules such as TAK1, TBK1 and IKKε (Fig. 1).
Although overlapped molecules remain to be clearly defined,
present data have suggested complex and interesting crosstalk
among the pathways.
Crosstalk between NF-κB activation pathways
Several independent studies suggest that TRIF interacts
with TRAF6 and thereby directly activates NF-κB (Sato et
al., 2003; Han et al., 2004; Jiang et al., 2004; Xu et al.,
2005). However, TLR3 signaling in TRAF6-deficient
macrophages is not affected, indicating that although TRIF
associates with TRAF6 in vivo, TRAF6 is not required for
the TLR3/TRIF-mediated NF-κB activation. In contrast,
TRAF6 plays a critical role in MyD88-mediated NF-κB
activation (Gohda et al., 2004). Recent studies showed that
RIP1 is involved in TLR3- and TLR4-dependent TRIF-
mediated NF-κB activation pathways (Balachandran et al.,
2004; Meylan et al., 2004; Cusson-Hermance et al., 2005).
However, there also exist some distinct explanations about
the involvement of RIP1 in TRIF-mediated NF-κB activa-
tion. It has been suggested that TRIF interacts with RIP1,
and this interaction mediates TLR3-triggered NF-κB activa-
tion (Meylan et al., 2004; Cusson-Hermance et al., 2005).
By asking why the activation dynamics of NF-κB show
damped oscillatory behavior when cells are stimulated by
tumor necrosis factor α (TNFα) but stable behavior when
stimulated by LPS, however, Covert et al. (2005) proposed
that the activation of NF-κB by TRIF-dependent pathway is
a result of a secondary response to TNFα, which is induced
by IRF3 (activated by TLR4/TRIF-mediated pathway in the
first response to LPS) and signals through TNFα receptor
(TNFR)/RIP1 pathway to activate NF-κB (Fig. 2A).
Together, we may speculate a complex network of crosstalk
among TLR signaling for NF-κB activation (Fig. 2A).
Crosstalk between IRF3/7 activation pathways
Two IκB-related kinases, TBK1 and IKKε, were
demonstrated to activate IRF3 and IRF7 (Fitzgerald et al.,
2003). As a result, hosts have an alternative choice of TBK1
or IKKε at the bifurcation of TRIF-mediated activation of
IRF3/7. Indeed, viral infected MEFs are exclusively
dependent on TBK1 in activation of IRF3/7, whereas
TBK1 and IKKε can function redundantly for viral
activation of IRF3/7 in thymocytes and bone marrow
(BM)-derived macrophages (BMMs) (Perry et al., 2004).
In addition, studies by Han et al. (2004) suggest that IKKβ
can also phosphorylate IRF3 at site(s) belonging to the fiveconserved Ser/Thr residues. It is possible that selection of
kinases for IRF3/7 activation may be determined by
crosstalks between distinct signaling pathways or by
difference of cell types (discussed below) (Fig. 2B).
Crosstalk between intracellular dsRNA- and
B-DNA-triggered signaling pathways
Mda-5 and RIG-I recognize intracellular viral dsRNA and
initiate VISA-dependent signaling to activate antiviral
responses. Studies by Ishii et al. (2006) show that B-DNA
also triggers VISA-dependent signaling via B-DNA sensors
other than Mda-5 or RIG-I (Fig. 1). Collectively, these data
indicate that there exist a crosstalk between dsRNA and B-DNA
signaling pathways.
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Stimulated by the specific PAMPs, the TLR-dependent and
-independent pathways converge at the activation of the
transcription factors NF-κB, IRF3/7 and/or AP-1, which
collaborate to induce production of a large number of cytokines,
most of which are undetectable in rest cells. Misactivation of
these genes may lead to serious diseases such as allergy. Thus,
the appropriate and precise regulations of transcription of the
downstream genes are essential for mammals to fight against
and clear the non-self-invaders as well as to protect themselves.
Recent advancement suggests increasing evidence that indicates
multistage regulations of gene transcription.
Promoter-specific regulation
The promoter of each downstream gene contains one or more
transcription factor binding sites. For example, the promoter of
IFN-β contains NF-κB binding sites (κB sites), a site for AP-1
and two IFN-stimulated responsive elements (ISREs) recog-
nized by phosphorylated IRF3/7. Previous studies showed that
the usage of regulatory corepressors/coactivators recruited to
DNA binding transcription factors plays an important role for
regulation of gene transcription (Xu et al., 1998; Asahara et al.,
1999; Li et al., 2002; Perissi et al., 2004). In a recent study,
Leung et al. (2004) demonstrated that the activation of IP10 but
not MCP-1 promoter, both of which contain two κB sites
differed in one and two nucleotides, requires IRF3 as a
coactivator following LPS stimulation, suggesting that the κB
site sequence affects coactivators that are recruited to form
complex with the bound NF-κB dimer. By analyzing the de-
repressed genes identified in NCoR-deficient macrophages,
Ogawa et al. (2004) found that nuclear receptor corepressor
(NCoR) acts as a corepressor that selectively represses a
significant fraction of AP-1-targeted genes. More recently, it
was shown that the glucocorticoid receptor (GR) can selectively
transrepress the transcription of a subset of genes (such as
Scyb9), of which promoters utilize IRF3 as an essential
coactivator of NF-κB binding to the κB sites upon LPS
stimulation (Ogawa et al., 2005; Fig. 3b). Collectively, these
data indicate that promoter-specific recruitment of coactivators
and corepressors is critical for transcription of downstream
genes.
Signal-specific regulation
Different signals can induce transcription of a number of
overlapped downstream genes by activating different pathways.
For example, both dsRNA and LPS can activate transcription of
the IP10 gene (Ogawa et al., 2005). How the diverse pathways
differentially and precisely control the transcription of the
identical gene remains largely unknown. Earlier work by
Wietek et al. (2003) demonstrated that LPS/TLR4 – but not
dsRNA/TLR3 – triggered IRF3-mediated activation of ISRE
requires the p65 subunit of NF-κB as a coactivator, suggesting a
signal-specific requirement of coactivators for transcription of
genes. Recent work by Ogawa et al. (2005) showed that GRselectively transrepresses IRF3/7-dependent gene transcription
downstream of the MyD88 signaling pathways. For instance,
the transcription of IP10 can be activated both by dsRNA/
TLR3/TRIF signaling pathways and by CpG/TLR9/MyD88
signaling pathways. Interestingly, transcription of IP10 by the
CpG-triggered MyD88-dependent pathways but not the
dsRNA-triggered TRIF-dependent pathways is repressed by
GR. These lines of evidence collectively suggest a signal-
specific control for TLR-dependent gene transcription, and it is
essential to further understand the mechanisms for such a
specific regulation.
Cell type-specific regulation
By using a confocal and differential interference contrast
(DIC) microscopy, Honda et al. (2005) demonstrated that in
response to CpG DNA stimulation, plasmacytoid dendritic cells
(pDCs) transport CpG to endosomal vehicles where CpG
remains to sustain the activation of the TLR9/MyD88/IRF7
pathway for induction of IFNs, whereas cDCs and the
macrophage cell line RAW264.7 (RAW cells) deliver CpG to
lysosomes and fail to recruit MyD88 and IRF7 for robust IFN
production. In addition, a recent study on RIG-I−/−mice showed
that RIG-I is essential for induction of type I IFNs in fibroblasts
and cDCs infected by RNA viruses such as Newcastle disease
virus (DNV), vesicular stomatitis virus (VSV) and SenV. In
contrast, pDCs use the TLR system rather than RIG-I for viral
detection (Kato et al., 2005). Taken together, mammals can
regulate transcription of IFN genes in a cell type-specific
manner.
From available data, we speculate that the precise regulations
of PAMP-induced transcription of downstream genes are
controlled at promoter, signal and cell levels. Hosts are exposed
to various pathogens, and these pathogens may target different
types of cells. Each type of the targeted cells may preferentially
activate several pathways, leading to activation of NF-κB,
IRF3/7 and/or AP-1. The activated transcription factors
translocate into nucleus and recruit signal- or promoter-specific
coactivators or both to initiate transcription of a number of
downstream genes. The production of cytokines on one hand
may trigger secondary pathway(s) as ligands through autocrine
or/and paracrine (Stark et al., 1998; Covert et al., 2005) and on
the other hand may function to alarm and activate immune
system to facilitate hosts to clear the invading pathogens. These
processes collectively lead to precisely temporal and spatial
regulations of transcription of downstream genes induced by
PAMPs.
Perspective
Identification of intracellular PAMP sensor(s)
dsRNA has long been considered as a viral PAMP, and
intracellular viral dsRNA can trigger a large amount of IFN
production. However, a potential problem is that whether viral
dsRNA ever exists inside a cell upon viral infection and
replication, as viral nucleic acids are always wrapped with
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accumulation in cells (Levy and Marie, 2004). tenOever et al.
(2002) demonstrated that just overexpression of the MeV
(measles virus) nucleocapsid (N) protein without the generation
of dsRNA is sufficient for IRF3 activation. More interestingly, it
was found that the recognition of MeV nucleocapsid structures
triggers IRF3 activation, indicating a novel intracellular PAMP
detection system. Recently, it was demonstrated that double-
stranded B-form DNA derived from DNA viruses, bacteria,
mammals or chemical synthesis can trigger production of IFN-
α/β through a RIG-I-independent and VISA-dependent path-
way (Ishii et al., 2006). Further investigations are needed to
determine the sensor(s) that recognizes nucleocapsid and B-
form DNA as well as to fully elucidate these signaling
pathways.
The RIG-I/VISA pathway
Four independent groups including us reported an
identical adaptor protein VISA/IPS-1/MAVS/Cardif (Xu et
al., 2005; Kawai et al., 2005; Meylan et al., 2005; Seth et
al., 2005) and showed that it is required for virus-induced
expression of IFN-β and signals downstream of RIG-I.
However, some inconsistencies exist among these studies.
For example, Kawai et al. (2005) showed that IPS-1
interacts with FADD and RIP1 to mediate NF-κB activation.
In contrast, Seth et al. (2005) failed to detect an interaction
between MAVS and RIP1 and FADD. These contradictions
need to be cleared in the future, and a fully understanding
of the physiological function of VISA needs a comprehen-
sive consideration of the signaling networks.
TLR signaling and adaptive immunity
Upon stimulation, innate immune cells, such as DCs and
macrophages, phagocytose pathogens and present the pathogen-
derived antigens to naive T cells. TLR signaling functions in the
processes of phagocytosis of microbial pathogens and phago-
some maturation and TLR-mediated expression of genes such
as costimulatory molecules facilitates to mount adaptive
immune responses (Beutler, 2004; Blander and Medzhitov,
2004; Doyle et al., 2004). In addition to this, two most recent
studies reveal that TLR signaling and antigen presentation can
communicate at other levels. Experiments by Blander and
Medzhitov (2006) demonstrated that presentation of peptide
antigens by the major histocompatibility complex class II
molecules (MHC II) to T cells is dependent on the concomitant
TLR engagement with the peptide antigens and ligand derived
from microbial pathogens. According to this, DCs can
discriminate different sources of antigens as self or non-self at
the subcellular level. By using a forward genetic approach
(Beutler et al., 2006), Tabeta et al. (2006) identified an
endoplasmic reticulum resident protein, UNC-93B, which is
critical for TLR3, 7 and 9 signaling as well as for exogenous
antigen processing and/or cross-presentation, suggesting that
TLR signaling and antigen presentation also communicate at the
organellar system. It is of interest and importance to elucidatethe mechanisms of UNC-93B regulating TLR signaling and
antigen presentation.
Clinical remarks
Evolutionary competition between hosts and viruses has
never stopped. Although hosts can recognize the PAMPs
presented by viruses and activate various pathways to clear
the infectious viruses, many viruses have also evolved
strategies to inhibit host immune responses and evade host
immunity. Three well-established examples are that the V
protein of paramyxoviruses, the P protein of rabies viruses
and the nonstructural protein-1 of rotaviruses can function to
disrupt signaling pathways that lead to transcriptional
activation of IFN-α/β (Andrejeva et al., 2004; Brzózka et
al., 2005; Barro and Patton, 2005; Conzelmann, 2005). As
for hepatitis C virus (HCV), its NS3/4A has serine protease
activity that enables it to cleave TRIF and VISA, two key
adaptors for innate immune responses, and the cleavage
results in reduction of IFNs and disruption of innate
immune responses as well as persistency of HCV (Li et
al., 2005b,c; Meylan et al., 2005). It is expected that drugs
would be developed to target or to be targeted by NS3/4A
for the treatment of persistent HCV infection.
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